O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway

Bibliographic Details
Main Authors: Øyvind Molberg, Sella A Provan, Karoline Lerang, Cathrine Brunborg, Hilde Haukeland, Sigrid R Moe, Torild Garen, Antonela Botea, Anniken Orre, Heidi Øvreås, Thea Bøe, Gro Å Wivestad, Nenad Damjanic
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Lupus Science and Medicine
_version_ 1797260059123646464
author Øyvind Molberg
Sella A Provan
Karoline Lerang
Cathrine Brunborg
Hilde Haukeland
Sigrid R Moe
Torild Garen
Antonela Botea
Anniken Orre
Heidi Øvreås
Thea Bøe
Gro Å Wivestad
Nenad Damjanic
author_facet Øyvind Molberg
Sella A Provan
Karoline Lerang
Cathrine Brunborg
Hilde Haukeland
Sigrid R Moe
Torild Garen
Antonela Botea
Anniken Orre
Heidi Øvreås
Thea Bøe
Gro Å Wivestad
Nenad Damjanic
author_sort Øyvind Molberg
collection DOAJ
first_indexed 2024-04-24T23:19:18Z
format Article
id doaj.art-3106ac183dc24aa3aae310d00684e834
institution Directory Open Access Journal
issn 2053-8790
language English
last_indexed 2024-04-24T23:19:18Z
publishDate 2024-03-01
publisher BMJ Publishing Group
record_format Article
series Lupus Science and Medicine
spelling doaj.art-3106ac183dc24aa3aae310d00684e8342024-03-16T19:55:09ZengBMJ Publishing GroupLupus Science and Medicine2053-87902024-03-0111Suppl 110.1136/lupus-2024-el.44O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in NorwayØyvind Molberg0Sella A Provan1Karoline Lerang2Cathrine Brunborg3Hilde Haukeland4Sigrid R Moe5Torild Garen6Antonela Botea7Anniken Orre8Heidi Øvreås9Thea Bøe10Gro Å Wivestad11Nenad Damjanic123Dept. of Rheumatology, Oslo University Hospital, Oslo, NorwayCenter for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, NorwayDepartment of Rheumatology, Oslo University Hospital, Oslo, Norway10Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway3Dept. of Rheumatology, Martina Hansens Hospital, Gjettum, Norway1Dept. of Rheumatology, Oslo University Hospital, Oslo, Norway1Dept. of Rheumatology, Oslo University Hospital, Oslo, Norway4Dept. of Rheumatology, Betanien Hospital, Skien, Norway5Dept. of Rheumatology, Vestre Viken Hospital Trust, Drammen, Norway6Dept. of Rheumatology, Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway7Dept. of Internal Medicine, Vestfold Hospital Trust, Tonsberg, Norway8Division of Rheumatology, Dept. of Medicine, Hospital of Southern Norway Trust, Kristiansand, Norway9Dept. of Rheumatology, Ostfold Hospital Trust, Graalum, Norway
spellingShingle Øyvind Molberg
Sella A Provan
Karoline Lerang
Cathrine Brunborg
Hilde Haukeland
Sigrid R Moe
Torild Garen
Antonela Botea
Anniken Orre
Heidi Øvreås
Thea Bøe
Gro Å Wivestad
Nenad Damjanic
O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
Lupus Science and Medicine
title O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
title_full O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
title_fullStr O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
title_full_unstemmed O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
title_short O35 Timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome; results from a population-based study set in Norway
title_sort o35 timing of thromboembolic events in systemic lupus erythematosus associated to antiphospholipid syndrome results from a population based study set in norway
work_keys_str_mv AT øyvindmolberg o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT sellaaprovan o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT karolinelerang o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT cathrinebrunborg o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT hildehaukeland o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT sigridrmoe o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT torildgaren o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT antonelabotea o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT annikenorre o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT heidiøvreas o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT theabøe o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT groawivestad o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway
AT nenaddamjanic o35timingofthromboemboliceventsinsystemiclupuserythematosusassociatedtoantiphospholipidsyndromeresultsfromapopulationbasedstudysetinnorway